[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371962-105":59,"doc-detail-371962-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-comprehensive-pan-cancer-analysis-of-the-prognostic-role-and-immunotherapy-efficacy-evaluation-of-glyoxalase-1","A comprehensive pan-cancer analysis of the prognostic role and immunotherapy efficacy evaluation of Glyoxalase 1","","Background: Glyoxalase 1 (GLO1) is an enzyme that degrades methylglyoxal (MG), a cytotoxic glycolysis byproduct, and is increasingly linked to tumor promotion. Methods: GLO1 mRNA expression was assessed using TCGA, and prognostic value was evaluated via Kaplan–Meier analysis. Protein expression was validated in clinical endometrial samples by immunohistochemistry, and associations with drug sensitivity (GDSC) and tumor microenvironment/immunotherapy response were analyzed. Results: GLO1 differed from adjacent normal tissues, and high levels predicted poor prognosis in 14 cancers; immune infiltration was negatively associated in breast cancer, and high expression correlated with worse immunotherapy outcomes in melanoma and kidney renal clear cell carcinoma.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-comprehensive-pan-cancer-analysis-of-the-prognostic-role-and-immunotherapy-efficacy-evaluation-of-glyoxalase-1/371962/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-comprehensive-pan-cancer-analysis-of-the-prognostic-role-and-immunotherapy-efficacy-evaluation-of-glyoxalase-1/371962.png","ImageObject",300,407,{"name":92,"@type":93},"dhado","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of analyzing GLOXALASE 1 (GLO1) in this pan-cancer study?","Question",{"text":112,"@type":113},"The study evaluates GLO1 expression across cancers, its prognostic significance, and its potential role in shaping immunotherapy response.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was GLO1 prognostic value assessed across multiple cancer types?",{"text":117,"@type":113},"GLO1 mRNA expression profiles were obtained from TCGA, and Kaplan–Meier analysis was used to evaluate prognostic value in multiple cancers.",{"name":119,"@type":110,"acceptedAnswer":120},"Which findings link high GLO1 with patient outcomes and immunotherapy?",{"text":121,"@type":113},"High GLO1 expression associated with poor prognosis in 14 cancers; it was negatively related to immune cell infiltration in breast invasive carcinoma, and high GLO1 correlated with poor immunotherapy outcomes in melanoma and kidney renal clear cell carcinoma.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},371962,1790997202,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Zhao et al. Discover Oncology (2025) 16:2326 [https://doi.org/10.1007/s12672-025-04109-3](https://doi.org/10.1007/s12672-025-04109-3)  \nDiscover Oncology  \nRESEARCH Open Access  \nA comprehensive pan-cancer analysis of the  prognostic role and immunotherapy efficacy evaluation of Glyoxalase 1  \nYi-Qi Zhao 1, Jue Zhao 1, Yan-Mei Zheng 1 and Qian-Qian Wang 1*  \n*Correspondence:  \nQian-Qian Wang [wangqian19860329@163.com](wangqian19860329@163.com)[ ](wangqian19860329@163.com)1Center for Reproductive Medicine, Department of Obstetrics, Zhejiang Provincial People′s Hospital, Affiliated People′s Hospital, Hangzhou Medical College, No. 158, Shangtang Road,  \nHangzhou 310000, Zhejiang, China  \nAbstract  \nBackground Glyoxalase 1 (GLO1), an enzyme responsible for breaking down methylglyoxal (MG), is increasingly recognized as a tumor-promoting factor due to its role in removing cytotoxic MG. This study aims to analyze the expression status and prognostic significance of GLO1 across various cancers and explore its potential role in cancer immunotherapy.  \nMethods We obtained GLO1 mRNA expression profiles from The Cancer Genome Atlas (TCGA) database. Kaplan-Meier analysis was used to evaluate the prognostic value of GLO1 in multiple cancers. We validated GLO1 protein expression in clinical endometrial cancer samples using immunohistochemical staining. Additionally, we analyzed GLO1’s correlation with drug sensitivity from the Genomics of Drug Sensitivity in Cancer (GDSC) database and its relationship with the tumor microenvironment and immunotherapy response.  \nResults GLO1 was widely expressed in human tumor tissues with significant differences compared to adjacent normal tissues. High GLO1 expression was associated with poor prognosis in 14 cancers, including adrenocortical carcinoma, cholangiocarcinoma, and lymphoid neoplasm diffuse large B-cell lymphoma. GLO1 expression was negatively related to immune cell infiltration in breast invasive carcinoma. In melanoma and kidney renal clear cell carcinoma, high GLO1 expression was linked to poor immunotherapy outcomes.  \nConclusions This comprehensive pan-cancer study reveals the prognostic value and potential predictive role of GLO1 in immunotherapy across multiple tumor types. This study primarily utilized bioinformatic datasets; experimental validation was performed for endometrial cancer but warrants expansion to other cancer types in future work. Keywords Glyoxalase 1, Pan-cancer, Prognostic biomarker, Immunotherapy, Tumor immune microenvironment  \n1 Introduction  \nGlyoxalase 1 (GLO1) is the key protein of glyoxalase system responsible for detoxifying methylglyoxal (MG), a cytotoxic byproduct of glycolysis. In the context of cancer, GLO1 has garnered significant attention due to its potential role in promoting tumor  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by-nc-nd/4.0/.  \nZhao et al. Discover Oncology (2025) 16:2326 Page 2 of 22  \nprogression. ELevated GLO1 expression has been associ","cbCaiaF2ODyvXMFv","https://ap.wps.com/l/cbCaiaF2ODyvXMFv","pdf",2499084,22,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the purpose of analyzing GLOXALASE 1 (GLO1) in this pan-cancer study?\",\"answer\":\"The study evaluates GLO1 expression across cancers, its prognostic significance, and its potential role in shaping immunotherapy response.\"},{\"question\":\"How was GLO1 prognostic value assessed across multiple cancer types?\",\"answer\":\"GLO1 mRNA expression profiles were obtained from TCGA, and Kaplan–Meier analysis was used to evaluate prognostic value in multiple cancers.\"},{\"question\":\"Which findings link high GLO1 with patient outcomes and immunotherapy?\",\"answer\":\"High GLO1 expression associated with poor prognosis in 14 cancers; it was negatively related to immune cell infiltration in breast invasive carcinoma, and high GLO1 correlated with poor immunotherapy outcomes in melanoma and kidney renal clear cell carcinoma.\"}]","A comprehensive pan-cancer analysis of the prognostic role and immunotherapy efficacy evaluation of Glyoxalase 1 | PDF",1790193333,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/adda2840f8829c2d4e5fd121986bb66b.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5bef5666398349ac4dd13aaba0feb313.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d35ce8790bbc1cb40fd3bb025b386b25.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a5c31bcaeb6ebd203edc55cab2bac09d.webp",980,1306]